Atrial Appendage Occluder Market - Global Industry Analysis

Atrial Appendage Occluder Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Category: Medical Device Report Format : PDF Report Code: ZMR-2157 Status : Upcoming

Description

Atrial Appendage Occluder Market: Overview

The atrial appendage is also known as the left atrial appendage (LAA). It is a pouch that is of the shape of the ear and is present in the human heart at the top left chamber. The proper functional significance is unknown. The patients having the arrhythmic cardiovascular face certain conditions which include atrial fibrillation, blood clots in the left atrial appendage. These blood clots cause fatal strokes.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Atrial Appendage Occluder Market: Facts

Coherex Medical Inc. was acquired by the Biosense Webster. The medical device company completely focused on the development of the Coherex WaveCrest Left Atrial Appendage Occlusion System. Basically, this system was designed in order to forever occlude the left atrial appendage in the patients that have the high risk of atrial fibrillation; this helps in reducing the stroke cases that is caused due to the migration of the blood clots.

Atrial Appendage Occluder Market: Segmentation

The global market for the atrial appendage is fragmented into its indication type, positioning procedure, and the end-user industry. On the basis of the type of the indication, the global market is segregated into valvular atrial fibrillation and non-valvular atrial fibrillation. On the basis of the procedure of the positioning, the market is categorized into epicardial and endocardial. On the basis of the end-user industry, the market is divided into the clinics and hospitals.

Atrial Appendage Occluder Market: Growth Factors

The prime factor that attributes to support the growth of the market is the increasing number of the cardiovascular patients that are suffering from atrial fibrillation and thromboembolism. The change in the lifestyle of the people and the increasing number of people that are suffering from obesity, diabetes, and hypertension is increasing the demand for the devices, thus contributing to the market growth. There are certain factors that are restraining the growth of the market which includes the limited use of the LAA occluder for the patients that have high chances of bleeding and risk of stroke when on the anticoagulant therapy. The other factors that will restrain the growth of the market are the unfavorable policies and the complications that are related to the surgery.

Atrial Appendage Occluder Market: Regional Analysis

The region that is dominating the atrial appendage occluder market is the North America owing to the increasing number of the geriatric people. In the coming years, the European market will witness a significant market growth owing to the increasing cases of the people suffering from arrhythmia. The market will grow in the future owing to the fact that the people in the developing regions are at a higher risk of suffering from the cardiovascular diseases which will, in turn, have a positive effect on the growth of the market. The market will grow in Asia Pacific region owing to the rise in the number of people that are dying due to stroke.

Atrial Appendage Occluder Market: Competitive Players

The key market players that are involved in the atrial appendage occluder market include Boston Scientific, SentreHEART Inc., Occlutech, Coherex Medical, Inc., AtriCure, Inc., Appriva Medical Inc., St. Jude Medical, PFM Medical Ag., W. L. Gore & Associates, and Cardia, Inc.

Atrial Appendage Occluder Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed